Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 10/20 | 0.74 |
| ▸ | MMP7 | P09237 | 4/20 | 0.74 |
| ▸ | MMP12 | P39900 | 4/20 | 0.74 |
| ▸ | MMP13 | P45452 | 4/20 | 0.74 |
| ▸ | ACE | P12821 | 3/20 | 0.74 |
| ▸ | PDE4A | P27815 | 13/20 | 0.72 |
| ▸ | PDE4B | Q07343 | 13/20 | 0.72 |
| ▸ | PDE4C | Q08493 | 13/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 13/20 | 0.72 |
| ▸ | MMP2 | P08253 | 7/20 | 0.72 |
| ▸ | MMP3 | P08254 | 7/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6823172 | 0.87 | MMP1 (0.79) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL7302160 | 0.85 | PDE4A (0.69) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL6819965 | 0.83 | PDE4A (1.00) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL6822987 | 0.83 | PDE4A (1.00) | MMP1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6823491 | 0.82 | PDE4A (0.70) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL6820179 | 0.81 | PDE4A (0.72) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL6422745 | 0.80 | PDE4A (0.89) | MMP1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7858984 | 0.80 | PDE4A (0.69) | MMP1MMP7MMP12MMP13ACE | |
| SCHEMBL6422449 | 0.79 | PDE4A (0.87) | MMP1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6425155 | 0.79 | PDE4A (0.83) | MMP1PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0871439-B1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | AVENTIS PHARMA INC (US) | 2004-03-31 | — | — | EP | claimed |
| US-6057369-A | USE IN THE TREATMENT OF DISEASE STATES ASSOCIATED WITH PROTEINS THAT MEDIATE CELLULAR ACTIVITY WHICH ARE CAPABLE OF BEING MODULATED BY INHIBITING A MATRIX METALLOPROTEINASE (MMP), TUMOR NECROSIS FACTOR (TNF) OR CYCLIC AMP | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 2000-05-02 | — | — | US | claimed |
| EP-0871439-A4 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE POULENC RORER PHARMA (US) | 1999-07-21 | — | — | EP | claimed |
| EP-0871439-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1997024117-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | claimed |
| EP-0871439-B1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | AVENTIS PHARMA INC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-6057369-A | USE IN THE TREATMENT OF DISEASE STATES ASSOCIATED WITH PROTEINS THAT MEDIATE CELLULAR ACTIVITY WHICH ARE CAPABLE OF BEING MODULATED BY INHIBITING A MATRIX METALLOPROTEINASE (MMP), TUMOR NECROSIS FACTOR (TNF) OR CYCLIC AMP | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0871439-A4 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE POULENC RORER PHARMA (US) | 1999-07-21 | — | — | EP | disclosed |
| EP-0871439-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1997024117-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | disclosed |